Abstract
The development of more active C–H oxidation catalysts has inspired a rapid, scalable, and stereoselective assembly of multifunctional piperazines through a [3+3] coupling of azomethine ylides. A combination of visible-light irradiation and aluminum organometallics is essential to promote this transformation, which introduces visible-light photochemistry of main-group organometallics and sets the basis for new and promising catalysts.
Keywords: aluminum, cycloaddition, heterocycles, oxidation, photochemistry
The aggregation of homogeneous catalysts in solution is an obscure phenomenon whose influence is rarely addressed in catalytic studies, thus leading to off-cycle catalyst depletion and/or mechanistic misinterpretation.[1] Deactivation of some important oxidation catalysts are linked to oligomerization,[2] which we aim to address using new piperazine ligands. Piperazines decorated with pyridine (and related) substituents are analogues of pyridylamine ligands relevant to water oxidation,[3] epoxidation of olefins,[4] and C–H oxidation of alkanes.[5] Although these heterocycles are ubiquitous in inorganic chemistry,[6] medicinal chemistry,[7] and natural products,[7a, 8] at the onset of our work only long syntheses with problems regarding stereocontrol could be foreseen towards piperazines functionalized at all carbon positions.[6–8] This challenge inspired the direct intermolecular photoreaction, reported herein, to prepare polyfunctional piperazines in one stereoselective and scalable transformation, thus using readily available modular precursors and a unique conceptual basis.
Imines (1) are versatile compounds which can be easily synthesized from libraries of simple aldehydes and amines (Scheme 1 a). Upon treatment with a base and a chelating metal, imines (1) can generate powerful azomethine ylide intermediates (2), which dimerize through a [3+2] cycloaddition in the absence of an electron-deficient dipolarophile.[9] We envisioned that rerouting the reactivity of azomethine ylides into a [3+3] cycloaddition[10] would be the ideal strategy to access carbon-functionalized piperazines in one step. At the onset of this work, this process had rarely been documented,[11] often only as a minor side-reaction.[12] The feasibility of our approach is partly supported by the reports of the groups of Gibson[12b] and Xia-Li[12a] on the dimerization of titanium complexes derived from the imines 1′a,b, which bear anionic substituents (Scheme 1 b).[12a,g] Unfortunately, in-house experimentation aimed at extending this chemistry to substrates with the desired neutral substituents proved fruitless (see the Supporting Information),[13] probably because of an insufficient driving force and/or fast retro-cycloaddition.[14]
Scheme 1.
Visible light reroutes the native reactivity of aluminum azomethine ylides.
Azomethine ylides bearing pyridine substituents (smifs)[14e] have been extensively studied in transition-metal complexes[14a–c] and are reported to absorb visible light, thus stimulating charge transfer from the aza-allyl anion to the pyridine ring (2 a→2 a*; Scheme 1 c).[14c, 15] We reasoned that intramolecular photostimulated electron transfer[16, 17] could generate a key ylide diradical state, capable of circumventing the problematic ground-state [3+3] cycloaddition.[18] Herein, we report an original combination of visible-light irradiation and an aluminum organometallic promoter which enables a practical and scalable synthesis of polyfunctional piperazines through a [3+3] dimerization reaction. The process allows access to carbon-functionalized piperazine products in one step, with complete stereoselectivity, and through a redox-neutral[19] and strategic [3+3] disconnection.[18] The two C–C bonds in the ring are created in the same transformation, as opposed to traditional piperazine syntheses, based on multistep sequences of cyclization and reduction reactions (ketopiperazine,[20] pyrazine reduction[21] or intramolecular aza-pinacol coupling).[22] Using the best combination of these methods, a piperazine product like 3 a (see Table 1) would take no less than four steps in the making (even longer for more elaborated substituents or unsymmetrical analogs),[22a, 23] thus discouraging its exploration in catalysis.
Table 1.
Optimization of the dimerization of 1 a with aluminum reagents[a]
Entry | Reagent | Solvent[b] | Light | Yield [%][c] | |
---|---|---|---|---|---|
3 a | 4 | ||||
1 | [Al(NR2)3]2[d] | toluene | CFL[e] | 0 | 0 |
2 | Al(OtBu)3 | toluene | CFL[e] | 0 | 0 |
3 | AlPh3 | toluene | CFL[e] | 0 | 0 |
4 | AlMe3 | toluene | CFL[e] | 56 | 15 |
5 | AlMe3 | THF | CFL[e] | 60 | 2 |
6 | AlMe3 | THF | W[g] | 58 | 2 |
7 | AlMe3 | THF | LED[h] | 89 | 3 |
8 | AlMe3 | THF | LED[h] | 74[i] | 2[i] |
9 | AlMe3 | THF | LED[h] | 11[f] | 23[f] |
10 | AlMe3 | THF | none | 11 | 3 |
[a] Reaction conditions: imine 1 a (0.2 mmol), Me3Al (0.2 mmol), solvent (0.2 mL), 0 °C to RT, 4 h. [b] Degassed by three freeze-pump-thaw cycles. [c] Yields determined by 1H NMR spectroscopy using 1,1,2,2-tetrachloroethane as an internal standard. [d] NR2=pyrrolidin-1-yl.[24] [e] Cold fluorescent bulb 20W (1230 lm). [f] Solvent not degassed. [g] Tungsten filament bulb 100 W. [h] 14.4 W cold white LED strip (1100 lm). [i] Reaction time 24 h. CFL=compact fluorescent light, LED=light-emitting diode, THF=tetrahydrofuran.
Our study focused on aluminum reagents, inspired by a report in which small traces of the piperazine 3 a were detected, using a related amine substrate.[12c,d] Initially, we tested our photochemical hypothesis on the imine 1 a using a cold white fluorescent bulb (Table 1). Having in mind that high-energy diradical species could be generated in this process, we took special precautions to remove oxygen from the system. While aluminum amides, alkoxides, and aromatic organometallics were proven ineffective (entries 1–3), Me3Al in toluene produced the desired product 3 a in moderate yield (entry 4). The main competitive by-product was the amine 4, which stems from methyl transfer to the imine carbon atom in 1 a. Gratifyingly, this by-product is minimized when using tetrahydrofuran as the solvent (entry 5). Different light sources were screened (entries 5–7), among which white LEDs were optimal in performance and reproducibility [(89±3) % yield, N=9]. Relevant control experiments revealed that extensive over-irradiation has only a moderate deleterious effect (entry 8), whereas deoxygenation is far more crucial (entry 9). Visible-light irradiation is essential to observe the desired reactivity (entry 10), and pleasingly supports our original hypothesis.
Additional control experiments demonstrate that this reaction is initiated by the formation of a Me2Al(smif) complex (2 a) accelerated by visible-light irradiation and characteristic of the organoaluminum manifold.[13] Me3Al is superior to any other Lewis acid or organometallic we have employed thus far (see Table S1 in the Supporting Information),[13] thereby taking a double role in this process by acting as a base and a [Me2Al]+ source. The acid-base reaction between 1 a and Me3Al can be monitored by NMR spectroscopy, thus allowing characterization of 2 a and the detection of methane as by-product (Scheme 2 a).[25] The formation of 2 a is also observed by using a mixture of Li(smif) 2 b and Me2AlCl, which upon light irradiation evolves to the piperazine 3 a in 65 % yield. Nevertheless, no 3 a is detected when either Me2AlCl or light irradiation is removed from this system, thus highlighting the essential role of both visible light and the [Me2Al]+ fragment on this reaction. The UV-VIS spectrum of 2 a (Scheme 2 b) presents strong absorptions at λ=394 and 570 nm, and are within the range of the intraligand bands (CNCnbo→Pyπ*) observed by Wolczanski and co-workers in transition-metal smif complexes [λ=(420±40) and (590±30) nm].[14b,c], [15] We have also monitored the reaction in the presence and absence of visible light (Scheme 2 c), thus observing a clear relationship between light irradiation periods and the formation of 3 a. All these results are fully consistent with the excited diradical intermediate 2 a*, which we reasonably propose.[26]
Scheme 2.
a) Characterization of 2 a and evolution to the piperazine 3 a: light and [Me2Al]+ are essential. b) UV-VIS spectrum of 2 a, featuring intraligand charge-transfer transitions.[14b] c) Formation of 3 a is clearly accelerated by visible light.
Using the optimal reaction conditions, we explored the reactivity of this system with the aim of developing ligands with diverse stereoelectronic properties (Scheme 3). First, it was found that alkyl groups are tolerated in all four available positions on the pyridine ring (3 a–e). The efficiencies are satisfactory with the notable exception of the 6-methyl-substituted product 3 e, thus suggesting that a strong interaction between aluminum and the heterocycle occurs in the course of the reaction (observed by NMR spectroscopy; Scheme 2 a). Electron-deficient (halogens or nitrile) and electron-donating (alkoxy) groups are incorporated into the piperazine products 3 f–h,jk. Other heterocyclic substituents were investigated to explore the limits of this reaction and obtain ligands with substantially different properties. While pyridine is ubiquitous in related bibliography,[12a–c,e], [14a] we were delighted to observe that other π-deficient (pyrazine: 3 i,ij) and π-excessive (imidazole: 3 j,ij,jk) heterocyclic substituents are seamlessly incorporated into our system. Remarkably, unsymmetrical imines bearing pyridine, pyrazine, and imidazole substituents are also excellent substrates, thus giving rise to 3 ij,jk, which feature opposite regioselectivity[27] to the ones found in previous systems (Scheme 1).[9, 12a,b] We find this regioselectivity suggestive of a distinct mechanism operating in this reaction. In all cases one diastereoisomer is detected in the crude reaction mixture and the products are efficiently isolated by direct recrystallization. All these features make this method amenable for scale-up, which we demonstrate for 3 a (2.27 g, 72 % yield), 3 i (1.22 g, 64 % yield), and 3 ij (1.15 g, 91 % yield). By taking advantage of their crystallinity, the structures of 3 b,g,ij have been confirmed using X-ray diffraction analysis.[28]
Scheme 3.
Scalable synthesis of piperazines. [a] Yield of isolated product is reported. The yield of the crude reaction mixture was determined by 1H NMR spectroscopy and is given within parentheses. See the Supporting Information. [b] Reaction time 20 h. [c] Reaction time 16 h.
Diastereomerically pure piperazines (3), are rigid analogues of relevant pyridylamine ligands like 6 (TPA; Scheme 4 a), which has led to important catalysts for water oxidation,[3] epoxidation of olefins,[4] and C–H oxidation of alkanes.[5] Iron pyridylamine catalysts suffer from a fast deactivation in the presence of water (coming from aqueous H2O2), thus forming stable oxo-bridged dimers (Scheme 4 a).[2] Therefore new catalysts which exhibit a superior tolerance to water would minimize the main deactivation pathway.[2] With gram quantities of 3 a in hand, we elaborated it to the densely functionalized ligand 5 (PiPy6; Scheme 4 b), which is closely related to 6. Aiming to discern the effect of the piperazine nucleus on the dimerization of iron catalysts, we treated 5 with Fe(OTf)2 and excess water. We were delighted to observe the formation of the dinuclear monomeric complex 7 (confirmed by X-ray diffraction analysis),[28] lacking the intermetallic oxo bridges (Fe-O-Fe) which are commonly found in FeTPA hydrates.[2a, 29] A preliminary study revealed that unlike FeTPA, the oxo-briged dimeric species derived from 7, were not detected in solution, even at high concentrations of water. As a result, the catalytic performance of 7 is superior to the parent FeTPA in a challenging alkane C–H oxidation reaction (Scheme 4 c).[5] The complex 7 is an active catalyst that performs metal-centered (non-Fenton) stereoretentive oxidation using aqueous H2O2, with a 60 % increased activity compared to that of FeTPA. Taking advantage of the basic difference between FeTPA and 7 (which we believe is a consequence of its dinuclear design), we plan to develop more elaborated (and active) catalysts for this[5] and other oxidation reactions[3, 4] based on the singular, rigid, three-dimensional topology defined by the densely functionalized piperazines which are now available.[14a,c]
Scheme 4.
a) Iron pyridylamine complexes dimerize readily in the presence of trace amounts of water. b) The dinuclear Fe2PiPy6 complex 7 is monomeric at high water concentrations. c) 7 is more active than FeTPA in stereoretentive C–H oxidation of alkanes with aqueous H2O2. Tf=trifluoromethanesulfonyl.
In summary, we have developed a scalable and stereoselective synthesis of polar piperazine compounds through a [3+3] cycloaddition of azomethine ylides. This way, densely functionalized piperazines become available in one step from readily available imine starting materials. The visible-light photoinduced electron transfer of aluminum organometallics, introduced herein, has been demonstrated to be essential for this transformation and has the potential to unveil other practical reactions with unique selectivity profiles in the future. This reaction gives access to new relevant ligands in meaningful quantities and is of strategic importance to further developments in catalysis. An in-depth understanding of this reaction and further application of the concepts and products presented herein are being documented in our laboratories and will be reported in due course.
Experimental Section
A vial was charged under argon atmosphere with a solution of imine 1 (0.2 mmol, 1.0 equiv) in freshly degassed anhydrous THF (0.2 mL). The solution was cooled down to 0–4 °C and AlMe3 (1.0 equiv) was added dropwise under white LED irradiation and further stirred for 4–24 h, as specified. Then, the reaction mixture was quenched by careful addition of deionized water, CHCl3, and NaOH (see the Supporting Information for details). The solids were filtered off, the filtrate concentrated in vacuo, and purified by recrystallization, to obtain pure piperazine 3.
Acknowledgments
The authors are indebted to the personnel of the Dept. of Organic Chemistry, the Dept. of Materials and Environmental Chemistry (SU) and AstraZeneca AB (Dr. B. Holm) for unrestricted support. Financial support to this work was provided by the Swedish Research Council (Vetenskapsrådet, 2012-2969), the Marie Curie Actions (631159), the Swedish Innovation Agency VINNOVA through the Berzelii Center EXSELENT, AstraZeneca AB, and Stockholm University.
Supporting Information
As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re-organized for online delivery, but are not copy-edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.
miscellaneous_information
References
- 1a.Weber D, Gagne MR. Chem. Sci. 2013;4:335–338. doi: 10.1039/C2SC21281A. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 1b.Baxter RD, Sale D, Engle KM, Yu J-Q, Blackmond DG. J. Am. Chem. Soc. 2012;134:4600–4606. doi: 10.1021/ja207634t. [DOI] [PubMed] [Google Scholar]
- 1c.Kina A, Iwamura H, Hayashi T. J. Am. Chem. Soc. 2006;128:3904–3905. doi: 10.1021/ja060225v. [DOI] [PubMed] [Google Scholar]
- 1d.Rosner T, Le Bars J, Pfaltz A, Blackmond DG. J. Am. Chem. Soc. 2001;123:1848–1855. doi: 10.1021/ja003191e. [DOI] [PubMed] [Google Scholar]
- 1e.Nielsen LPC, Stevenson CP, Blackmond DG, Jacobsen EN. J. Am. Chem. Soc. 2004;126:1360–1362. doi: 10.1021/ja038590z. [DOI] [PubMed] [Google Scholar]
- 2a.Korendovych IV, Kryatov SV, Reiff WM, Rybak-Akimova EV. Inorg. Chem. 2005;44:8656–8658. doi: 10.1021/ic051739i. [DOI] [PubMed] [Google Scholar]
- 2b.Vermeulen NA, Chen MS, White MC. Tetrahedron. 2009;65:3078–3084. [Google Scholar]
- 2c.Gómez L, Canta M, Font D, Prat I, Ribas X, Costas M. J. Org. Chem. 2013;78:1421–1433. doi: 10.1021/jo302196q. [DOI] [PubMed] [Google Scholar]
- 2d.Gómez L, Garcia-Bosch I, Company A, Benet-Buchholz J, Polo A, Sala X, Ribas X, Costas M. Angew. Chem. Int. Ed. 2009;48:5720–5723. doi: 10.1002/anie.200901865. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2009;121 [Google Scholar]
- 2e.Yazerski VA, Spannring P, Gatineau D, Woerde CHM, Wieclawska SM, Lutz M, Kleijn H, Klein Gebbink RJM. Org. Biomol. Chem. 2014;12:2062–2070. doi: 10.1039/c3ob42249f. [DOI] [PubMed] [Google Scholar]
- 3.Wang H-Y, Mijangos E, Ott S, Thapper A. Angew. Chem. Int. Ed. 2014;53:14499–14502. doi: 10.1002/anie.201406540. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2014;126 [Google Scholar]
- 4a.Chen K, Costas M, Kim J, Tipton AK, Que L. J. Am. Chem. Soc. 2002;124:3026–3035. doi: 10.1021/ja0120025. [DOI] [PubMed] [Google Scholar]
- 4b.Fujita M, Costas M, Que L. J. Am. Chem. Soc. 2003;125:9912–9913. doi: 10.1021/ja029863d. [DOI] [PubMed] [Google Scholar]
- 4c.Oloo WN, Meier KK, Wang Y, Shaik S, Munck E, Que L. Nat. Commun. 2014;5:3046. doi: 10.1038/ncomms4046. [DOI] [PubMed] [Google Scholar]
- 4d.Zang Y, Kim J, Dong Y, Wilkinson EC, Appelman EH, Que L. J. Am. Chem. Soc. 1997;119:4197–4205. [Google Scholar]
- 5a.Chen K, Que L., Jr Chem. Commun. 1999:1375–1376. [Google Scholar]
- 5b.Chen K, Que L. J. Am. Chem. Soc. 2001;123:6327–6337. doi: 10.1021/ja010310x. [DOI] [PubMed] [Google Scholar]
- 6a.Hancock SL, Mahon MF, Jones MD. Dalton Trans. 2011;40:2033–2037. doi: 10.1039/c0dt01542c. [DOI] [PubMed] [Google Scholar]
- 6b.Zhang Z, Xu X, Sun S, Yao Y, Zhang Y, Shen Q. Chem. Commun. 2009:7414–7416. doi: 10.1039/b915414k. [DOI] [PubMed] [Google Scholar]
- 6c.Paital AR, Mandal D, Huang X, Li J, Aromí G, Ray D. Dalton Trans. 2009:1352–1362. doi: 10.1039/b814681k. [DOI] [PubMed] [Google Scholar]
- 6d.Fallon GD, Murray KS, Spethmann B, Yandell JK, Hodgkin JH, Loft BC. J. Chem. Soc. Chem. Commun. 1984:1561–1563. [Google Scholar]
- 7a.Borthwick AD. Chem. Rev. 2012;112:3641–3716. doi: 10.1021/cr200398y. [DOI] [PubMed] [Google Scholar]
- 7b.Welsch ME, Snyder SA, Stockwell BR. Curr. Opin. Chem. Biol. 2010;14:347–361. doi: 10.1016/j.cbpa.2010.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7c.Horton DA, Bourne GT, Smythe ML. Chem. Rev. 2003;103:893–930. doi: 10.1021/cr020033s. [DOI] [PubMed] [Google Scholar]
- 7d.Esnouf RM, Ren J, Hopkins AL, Ross CK, Jones EY, Stammers DK, Stuart DI. Proc. Natl. Acad. Sci. USA. 1997;94:3984–3989. doi: 10.1073/pnas.94.8.3984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7e.Tagat JR, Steensma RW, McCombie SW, Nazareno DV, Lin S-I, Neustadt BR, Cox K, Xu S, Wojcik L, Murray MG, Vantuno N, Baroudy BM, Strizki JM. J. Med. Chem. 2001;44:3343–3346. doi: 10.1021/jm0155401. [DOI] [PubMed] [Google Scholar]
- 8a.Garg NK, Sarpong R, Stoltz BM. J. Am. Chem. Soc. 2002;124:13179–13184. doi: 10.1021/ja027822b. [DOI] [PubMed] [Google Scholar]
- 8b.Nicolaou KC, Totokotsopoulos S, Giguere D, Sun YP, Sarlah D. J. Am. Chem. Soc. 2011;133:8150–8153. doi: 10.1021/ja2032635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8c.Wang H, Reisman SE. Angew. Chem. Int. Ed. 2014;53:6206–6210. doi: 10.1002/anie.201402571. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Angew. Chem. 2014;126 [Google Scholar]
- 8d.Codelli JA, Puchlopek AL, Reisman SE. J. Am. Chem. Soc. 2012;134:1930–1933. doi: 10.1021/ja209354e. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8e.Corey EJ, Gin DY, Kania RS. J. Am. Chem. Soc. 1996;118:9202–9203. [Google Scholar]
- 9.Erkizia E, Aldaba E, Vara Y, Arrieta A, Gornitzka H, Cossio FP. ARKIVOC. 2005;2005:189–199. [Google Scholar]
- 10a.Guo H, Liu H, Zhu F-L, Na R, Jiang H, Wu Y, Zhang L, Li Z, Yu H, Wang B, Xiao Y, Hu X-P, Wang M. Angew. Chem. Int. Ed. 2013;52:12641–12645. doi: 10.1002/anie.201307317. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2013;125 [Google Scholar]
- 10b.He Z-L, Teng H-L, Wang C-J. Angew. Chem. Int. Ed. 2013;52:2934–2938. doi: 10.1002/anie.201208799. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2013;125 [Google Scholar]
- 10c.Potowski M, Bauer JO, Strohmann C, Antonchick AP, Waldmann H. Angew. Chem. Int. Ed. 2012;51:9512–9516. doi: 10.1002/anie.201204394. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2012;124 [Google Scholar]
- 10d.Yuan C, Liu H, Gao Z, Zhou L, Feng Y, Xiao Y, Guo H. Org. Lett. 2015;17:26–29. doi: 10.1021/ol503169d. [DOI] [PubMed] [Google Scholar]
- 10e.Shi F, Zhu R-Y, Dai W, Wang C-S, Tu S-J. Chem. Eur. J. 2014;20:2597–2604. doi: 10.1002/chem.201304187. [DOI] [PubMed] [Google Scholar]
- 11.Huisgen R, Niklas K. Heterocycles. 1984;22:21–26. [Google Scholar]
- 12a.Chen Z, Wu J, Chen Y, Li L, Xia Y, Li Y, Liu W, Lei T, Yang L, Gao D, Li W. Organometallics. 2012;31:6005–6013. [Google Scholar]
- 12b.Cariou R, Gibson VC, Tomov AK, White AJP. J. Organomet. Chem. 2009;694:703–716. [Google Scholar]
- 12c.Trepanier SJ, Wang S. Can. J. Chem. 1996;74:2032–2040. [Google Scholar]
- 12d. Wang and co-workers isolated 3 a, as a minor compound from a related amine. They stated explicitly that “independent synthesis of this compound has not been successful”.
- 12e.Westerhausen M, Bollwein T, Mayer P, Piotrowski H, Pfitzner A. Z. Anorg. Allg. Chem. 2002;628:1425–1432. [Google Scholar]
- 12f.Pearson WH, Szura DP, Postich MJ. J. Am. Chem. Soc. 1992;114:1329–1345. [Google Scholar]
- 12g. Two examples of free piperazines in milligram quantities are reported by Xia-Li (Ref. [12a]). Free piperazines are not reported in Gibson’s contribution (Ref. [12b])
- 13. We have also experimented with a plethora of other common Lewis acids and bases without success (see Table S1 in the Supporting Information)
- 14a.Frazier BA, Wolczanski PT, Lobkovsky EB, Cundari TR. J. Am. Chem. Soc. 2009;131:3428–3429. doi: 10.1021/ja8089747. [DOI] [PubMed] [Google Scholar]
- 14b.Frazier BA, Bartholomew ER, Wolczanski PT, DeBeer S, Santiago-Berrios M, Abruna HD, Lobkovsky EB, Bart SC, Mossin S, Meyer K, Cundari TR. Inorg. Chem. 2011;50:12414–12436. doi: 10.1021/ic200376f. [DOI] [PubMed] [Google Scholar]
- 14c.Frazier BA, Williams VA, Wolczanski PT, Bart SC, Meyer K, Cundari TR, Lobkovsky EB. Inorg. Chem. 2013;52:3295–3312. doi: 10.1021/ic302783y. [DOI] [PubMed] [Google Scholar]
- 14d. Fe-smif complexes by Wolczanski and co-workers exist in equilibrium with piperazine dinuclear species (Ref. [14a]), which is shifted to the latter only in the solid state. This behavior (and potential iron contamination) makes this approach unsuitable for the preparation of the free ligands.
- 14e. smif=1,3-di-(2-pyridyl)-2-azaallyl.
- 15. The UV-VIS spectra of smif complexes were assigned to charge-transfer transitions from CNC non-bonding orbitals to the heterocycle π* (CNC{nbo}→Py{π*}), with a small MLCT contribution.
- 16a.Ravelli D, Fagnoni M, Albini A. Chem. Soc. Rev. 2013;42:97–113. doi: 10.1039/c2cs35250h. [DOI] [PubMed] [Google Scholar]
- 16b.Fagnoni M, Dondi D, Ravelli D, Albini A. Chem. Rev. 2007;107:2725–2756. doi: 10.1021/cr068352x. [DOI] [PubMed] [Google Scholar]
- 16c.Bunte JO, Mattay J, Oelgemöller M. In: Synthetic Organic Photochemistry. Mattay J, Griesbeck A, editors. Boca Raton, FL: CRC; 2004. pp. 269–297. [Google Scholar]
- 17a.Arceo E, Jurberg ID, Alvarez-Fernandez A, Melchiorre P. Nat. Chem. 2013;5:750–756. doi: 10.1038/nchem.1727. For recent examples, see. [DOI] [PubMed] [Google Scholar]
- 17b.Arceo E, Bahamonde A, Bergonzini G, Melchiorre P. Chem. Sci. 2014;5:2438–2442. [Google Scholar]
- 17c.Silvi M, Arceo E, Jurberg ID, Cassani C, Melchiorre P. J. Am. Chem. Soc. 2015;137:6120–6123. doi: 10.1021/jacs.5b01662. [DOI] [PubMed] [Google Scholar]
- 17d.Beatty JW, Stephenson CR. J. Am. Chem. Soc. 2014;136:10270–10273. doi: 10.1021/ja506170g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17e.Hager D, MacMillan DW. J. Am. Chem. Soc. 2014;136:16986–16989. doi: 10.1021/ja5102695. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17f.Do H-Q, Bachman S, Bissember AC, Peters JC, Fu GC. J. Am. Chem. Soc. 2014;136:2162–2167. doi: 10.1021/ja4126609. [DOI] [PubMed] [Google Scholar]
- 17g.Huo H, Shen X, Wang C, Zhang L, Rose P, Chen L-A, Harms K, Marsch M, Hilt G, Meggers E. Nature. 2014;515:100–103. doi: 10.1038/nature13892. [DOI] [PubMed] [Google Scholar]
- 17h.Du J, Skubi KL, Schultz DM, Yoon TP. Science. 2014;344:392–396. doi: 10.1126/science.1251511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18a.Xu X, Doyle MP. Acc. Chem. Res. 2014;47:1396–1405. doi: 10.1021/ar5000055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18b.Harrity JPA, Provoost O. Org. Biomol. Chem. 2005;3:1349–1358. doi: 10.1039/b502349c. [DOI] [PubMed] [Google Scholar]
- 19a.Burns NZ, Baran PS, Hoffmann RW. Angew. Chem. Int. Ed. 2009;48:2854–2867. doi: 10.1002/anie.200806086. [DOI] [PubMed] [Google Scholar]
- Angew. Chem. 2009;121 [Google Scholar]
- 20a.Kojima S, Chabayashi T, Umeda Y, Iwamoto A, Tanabe K, Ohkata K. Heterocycles. 2008;75:1493–1501. [Google Scholar]
- 20b.Du Y, Creighton CJ, Falcone BV, Parker MH, Gauthier DA, Reitz AB. Tetrahedron Lett. 2007;48:6767–6770. [Google Scholar]
- 20c.Jung ME, Rohloff JC. J. Org. Chem. 1985;50:4909–4913. [Google Scholar]
- 21a.Kukula P, Prins R. J. Catal. 2002;208:404–411. [Google Scholar]
- 21b.Lunn G. J. Org. Chem. 1987;52:1043–1046. [Google Scholar]
- 21c.Miyake FY, Yakushijin K, Horne DA. Org. Lett. 2000;2:3185–3187. doi: 10.1021/ol0001970. [DOI] [PubMed] [Google Scholar]
- 22a.Mercer GJ, Sigman MS. Org. Lett. 2003;5:1591–1594. doi: 10.1021/ol034469l. [DOI] [PubMed] [Google Scholar]
- 22b.Shono T, Kise N, Shirakawa E, Matsumoto H, Okazaki E. J. Org. Chem. 1991;56:3063–3067. [Google Scholar]
- 23.Karlsson S, Lindberg J, Sörensen H. Org. Process Res. Dev. 2013;17:1552–1560. [Google Scholar]
- 24.Passarelli V, Carta G, Rossetto G, Zanella P. Dalton Trans. 2003:1284–1291. [Google Scholar]
- 25. The NMR data (including NOE interactions) clearly support the existence of 2 a as a tricoordinated, symmetrical pincer complex in solution. This structure may be responsible for the complete all-equatorial diastereoselectivity observed in this reaction.
- 26. A sluggish reaction occurs in the dark, and may resemble the diradical ground-state character of the smif anion; see Ref. [14b]
- 27. We found that unsymmetrical imines derived from pyridines lead to two regioisomers of the piperazine product.
- 28. CCDC 1052437 (3 ij), 1052438 (3 b), 1053734 (3 g), and 1052436 (7) contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre.
- 29a.Wilkinson EC, Dong Y, Que L. J. Am. Chem. Soc. 1994;116:8394–8395. [Google Scholar]
- 29b.Kojima T, Leising RA, Yan S, Que L. J. Am. Chem. Soc. 1993;115:11328–11335. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
miscellaneous_information